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Abstract: The release of tumor necrosis factor α (TNF-α) by ochratoxin A (OTA) was 
studied in various macrophage and non-macrophage cell lines and compared with E. coli 
lipopolysaccharide (LPS) as a standard TNF-α release agent. Cells were exposed either to  
0, 2.5 or 12.5 µmol/L OTA, or to 0.1 µg/mL LPS, for up to 24 h. OTA at 2.5 µmol/L and 
LPS at 0.1 µg/mL were not toxic to the tested cells as indicated by viability markers.  
TNF-α was detected in the incubated cell medium of rat Kupffer cells, peritoneal rat 
macrophages, and the mouse monocyte macrophage cell line J774A.1: TNF-α 
concentrations were 1,000 pg/mL, 1,560 pg/mL, and 650 pg/mL, respectively, for   
2.5 µmol/L OTA exposure and 3,000 pg/mL, 2,600 pg/mL, and 2,115 pg/mL, respectively, 
for LPS exposure. Rat liver sinusoidal endothelial cells, rat hepatocytes, human HepG2 
cells, and mouse L929 cells lacked any cytokine response to OTA, but showed a 
significant release of TNF-α after LPS exposure, with the exception of HepG2 cells. In 
non-responsive cell lines, OTA lacked both any activation of NF-κB or the translocation of 
activated NF-κB to the cell nucleus, i.e., in mouse L929 cells. In J774A.1 cells,   
OTA mediated TNF-α release via the pRaf/MEK 1/2–NF-κB and p38-NF-κB pathways, 
whereas LPS used pRaf/MEK 1/2-NF-κB, but not p38-NF-κB pathways. In contrast, in 
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L929 cells, LPS used other pathways to activate NF-κB. Our data indicate that only 
macrophages and macrophage derived cells respond to OTA and are considered as sources 
for TNF-α release upon OTA exposure. 
Keywords:  ochratoxin A; lipopolysaccharide; tumor necrosis factor α; Kupffer cells; 
macrophages; rat liver sinusoidal endothelial cells; HepG2 cells; rat hepatocytes  
Abbreviations: OTA—ochratoxin A; TNF—tumor necrosis factor;   
LPS—lipopolysaccharide; NF-κB—nuclear factor kappa B 
 
1. Introduction 
Ochratoxin A (OTA) is a natural mycotoxin produced from Aspergillus and Penicillium species. 
OTA causes diverse toxicological responses: it is genotoxic, carcinogenic, nephrotoxic, hepatotoxic, 
embryotoxic, teratogenic, and immunotoxic. Previous risk assessments have studied its genotoxicity 
and OTA-mediated nephrotoxicity [1–4]. It is also a strong immunosuppressant fungal compound [5]. 
The immune system has been considered as sensitive as the kidney though, because it was 
concomitantly affected by the lowest dose causing nephrotoxicity [6]. In addition to a reduction in size 
of vital immune organs, OTA immunotoxicity includes hypocellularity of bone marrow and 
impairment of immunoglobin responses [5]. Furthermore, its toxicity on rat livers triggers the release 
of inflammatory cytokines [7]. A marked release of TNF-α and IL-6 has been observed during 
perfusion of the isolated rat liver with OTA via the portal vein [8]. This rat liver-derived TNF-α 
originated from Kupffer cells [9]. Its release was affected by eicosanoids, whereby leucotrienes and 
CYP-450 metabolites stimulated cytokine release, whereas arachidonic acid and cyclooxygenase-
derived metabolites suppressed it [7]. 
In blood-free perfused rat livers, a synergistic effect on OTA-mediated TNF-α release by   
co-addition of low doses of E. coli lipopolysaccharides (LPS) has been observed [10] Thus, the 
question arises whether in general OTA mimics LPS-induced TNF-α release in all LPS-sensitive 
macrophage and non-macrophage cells, indicating a release pathway similar to the LPS-triggered 
cascade [11,12] Therefore, in this study we compared the ability of OTA to release TNF-α from 
macrophage and non-macrophage cells with LPS, and investigated the possible mediator mechanism 
of this release. 
2. Results and Discussion 
2.1. Cytotoxicity Effects of OTA and LPS 
Our previous studies have shown that OTA releases TNF-α from blood-free perfused rat livers in a 
dose- and time-dependent fashion without effects on liver vitality [7,9,13]. From these studies, we 
selected two OTA concentrations: 2.5 and 12.5 µmol/L. The cytotoxicity of OTA and LPS in this 
study was measured by MTT test (Table 1). Our results showed that 2.5 µmol/L OTA and 0.1 µg/mL 
LPS did not alter the survival of HepG2 cells, L929 cells, and J774A.1 cells in comparison with Toxins 2010, 2 
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untreated cells (vehicle). The reduction of viability and proliferation in non-macrophages cells 
(HepG2, L929) was generally less than 5%, whereas 2.5 µmol/L OTA (but not 0.1 µg/mL LPS) 
reduced survival by about 15% in the mouse macrophage cell line J774A.1. In addition, for Kupffer 
cells and peritoneal macrophages, reduction was no more than 15% as measured by MTT (data not 
shown). The staining of L929, HepG2 and J774A.1 with the LIVE/DEAD kit confirmed the MTT data 
(Figure 1). With five-times higher concentration of OTA, significant toxicity of the tested cells was 
observed (Table 1, Figure 1). Our data indicates that the cells used in our study, with the exception of 
J774A.1, resist direct toxicity of 2.5 µmol/L OTA or 0.1 µg/mL LPS during 24 hours of exposure. 
Thus, these concentrations were used for further experiments. 
Table 1. The cytotoxic effects of the vehicle, 2.5, and 12.5 µmol/L OTA and 0.1 µg/mL 
LPS after 24 h on J774A.1, HepG2, and L929 cell lines were detected by MTT test. OTA 
and LPS were added 1 h after zero samples (see Materials and Methods). Data are presented 
as percent of control cells exposed to vehicle: absorbance of 24 h exposed cells/absorbance 
of 24 h control cells. Values represent the mean ± SEM of five cultures for each group,  
(* P < 0.05; ** P < 0.01; *** P < 0.001) (Effect of OTA and LPS on cell viability). 
Percentages of cell viability after 24 h exposure to OTA or LPS (MTT) 
Cell type 
HepG2 cells  L929 cells  J774A.1 cells 
Treatments 
Control (vehicle)  100% 100% 100% 
2.5 µmol/L OTA  <95% ± 5  <95% ± 5  85% ± 9 * 
12.5 µmol/L OTA 75%  ± 10 **  60% ± 10 ***  30% ± 20 *** 
0.1 µg/mL LPS <95%  ± 5  <95% ± 5  <95% ± 5 
2.2. TNF-α Release from Primary Macrophages and Macrophage-like Cells 
In perfused rat livers, several types of cells may serve as a source of TNF-α, e.g., hepatocytes, 
sinusoidal endothelial cells, and Kupffer cells. In a previous study, OTA failed to induce TNF-α 
release in the blood-free perfused isolated rat liver when Kupffer cells were blocked in vitro by   
15 µmol/L gadolinium chloride or when rats were pretreated in vivo with the Kupffer cell depleting 
clodronate liposomes [9]. Additionally, OTA-mediated TNF-α release originated from purified 
isolated rat Kupffer cells but not from rat hepatocytes or rat sinusoidal endothelial cells [9]. In order to 
extend our understanding for the cell sensitivity for OTA, we measured in this study OTA-mediated 
TNF-α release from additional cells (Table 2). 
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Figure 1. The cytotoxic effects of OTA and LPS on HepG2, L929 and J774A.1 cells were 
detected by LIVE/DEAD kit after exposure to the vehicle, 2.5, 12.5 µmol/L OTA or   
0.1 µg/mL LPS up to 24 h. OTA and LPS were added 1 h after zero samples, (see 
Materials and Methods). The pictures were taken from at least five randomly selected 
square fields of microscope slides where we counted about 100 cells per field, The figure 
shows representative pictures for least three different individual experiments (Cytotoxicity 
of OTA and LPS). 
 
Table 2. TNF-α concentrations in the incubation medium of different cells at 24 h in the 
absence or presence of 2.5 µmol/L OTA or 0.1 µg/mL LPS. OTA and LPS were applied at 
1 h from zero time (see Materials and Methods). Values represent the mean ± SEM of  
three cultures for each group, (* P < 0.05; ** P < 0.01; *** P < 0.001) (TNF-α 
concentrations in incubation the medium at 24 h). 
Cell type 
TNF-α concentrations in incubation medium at 24 h 
Control (vehicle)  2.5 µmol/L OTA  0.1 µg/mL LPS 
Kupffer cells  131 ± 10  1000 ± 40 ***  3000 ± 50 *** 
Peritoneal macrophages  161 ± 10  1560 ± 90 ***  2600 ± 250 *** 
J774A.1 cell line  111 ± 5  635 ± 45 ***  2115 ± 60 *** 
Hepatocytes 47  ± 5  73 ± 5  776 ± 100 *** 
HepG2 cell line  36 ± 2  48 ± 10  36 
Sinusoidal endothelial cells  219 ± 10  235 ± 25  1925 ± 70 *** 
L929 cell line  47 ± 10  53 ± 10  92 ± 5 *** 
Primary rat macrophages, i.e., Kupffer cells and peritoneal macrophages, were exposed to the 
vehicle or a standard dose of 2.5 µmol/L OTA or 0.1µg/mL LPS, respectively, during 24 h in culture. Toxins 2010, 2 
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Kupffer cells (Figure 2(a)), which represent liver-placed resident macrophages, revealed basal   
TNF-α release in the absence of treatment (vehicle), which increased from 50 pg/mL at time zero to 
131 ± 10 pg/mL after 24 h. However, 10-times as much TNF-α was released within 24 h when OTA 
was added. Onset of release began slowly during the first 4 h in the presence of OTA, but reached 
1000 ± 40 pg/mL TNF-α (P < 0.001) at the end of the incubation period. Kupffer cells released TNF-α 
more rapidly and to a higher extent if exposed to 0.1 µg of LPS/mL. LPS caused significant (P < 0.001) 
release of TNF-α as early as 1 h after addition and reached 3000 ± 50 pg/mL after 24 h. Similarly, rat 
peritoneal macrophages (Figure 2(b)), representing non-residential freely movable macrophages, 
released basal TNF-α levels up to 161 ± 10 pg/mL in the absence of treatment (vehicle) after 24 h. An 
OTA concentration of 2.5 µmol/L stimulated these cells to release 1560 ± 90 pg TNF-α/mL after 24 h. 
The mycotoxin response on these cells was statistically significant (P < 0.01) at 4 h and became highly 
significant (P < 0.001) by the end of incubation (24 h), when TNF-α levels were 10-times higher than the 
basal TNF-α release. In response to 0.1 µg of LPS/mL, TNF-α was detected in the incubation medium 
after 1 h and became highly significant (P < 0.001) between 4 h and the end of incubation. After 24 h of 
LPS exposure, TNF-α concentrations reached 2600 ± 250 pg/mL. 
Figure 2. TNF-α concentrations were measured in incubation media of isolated cells in cell 
culture at 0, 0.5, 1, 1.5, 2, 4 and 24 h indicated by single columns 1–7, respectively. The 
cells were exposed to vehicle ( ), 2.5 µmol/L OTA ( ) or 0.1 µg/mL LPS ( ). 
Panel (a) Kupffer cells. Panel (b) Peritoneal macrophages. Panel (c) J774A.1 cell line. 
OTA and LPS were added 1 h after zero samples (see Materials and Methods). Values 
represent the mean ± SEM of three cell preparations for each group (* P < 0.05;   
** P < 0.01; *** P < 0.001) (TNF-α release from primary macrophages and macrophages  
like cells). 
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Figure 2. Cont. 
 
 
In order to confirm the effects of OTA-mediated TNF-α release from rat macrophages, we 
investigated the effects of tested compounds on J774A.1, a mouse monocyte macrophage cell line. 
(Figure 2(c)) shows TNF-α release from these cells. The basal cell release was 32 pg/mL of TNF-α at 
time point zero and 111 ± 5 pg/mL of TNF-α after 24 h in culture treated with the vehicle. In the 
presence of OTA, TNF-α level significantly increased (P < 0.05) at 4 h, then became significant  
(P < 0.001) by the end point (635 ± 45 pg/mL). Much higher TNF-α level was reached in the presence 
of 0.1 µg of LPS/mL. Here, the TNF-α concentration was 2115 ± 60 pg/mL at the end of the 24 h 
incubation, showing that the effect of LPS on J774A.1 cells was much faster and three-times stronger 
than that promoted by OTA. Table 2 summarizes the results obtained and the significance for TNF-α 
release at the endpoint of 24 h in this set of experiments. 
Other mycotoxins, i.e., fumonisins [14,15] and aflatoxins [16], have also been found to interact with 
Kupffer cells disturbing the phagocytic properties. In these cases, it was reported that this interaction 
adds to the hepatotoxicity of the mycotoxins. Comparable with OTA, the fumonisins also forced a Toxins 2010, 2 
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marked release of TNF-α from Kupffer cells [15]. Normally, antigen activation of Kupffer cells 
triggers vigorous activity for phagocytosis, during which they produce soluble mediators such as 
cytokines, prostanoids, oxygen radicals, and proteases [17]. While at low physiologic levels these 
mediators contribute to the physiological phagocytic process, their excessive production induces liver 
injuries [17,19]. We assume that mycotoxin-induced stimulation of Kupffer cells produces not only 
locally but even systemically circulating inflammatory mediators [20,22], as it occurs in response to 
gut-absorbed bacterial endotoxin LPS [22]. Furthermore, Kupffer-cell-derived mediators have been 
considered centrally responsible for switching and initiating several signaling cascades in hepatocytes, 
leading to apoptosis, but also to cell proliferation, and liver regeneration, especially in response to 
TNF-α [23,24]. Similar effects are expected under OTA exposure in murine livers where TNF-α 
mediated cell apoptosis was already reported [25,26]. 
Our observation of TNF-α release from macrophage cells by OTA contrasts with a report by Heller 
et al., 2002. In their experiments on the human monocyte cell line THP-1, a dose-dependent reduction 
of LPS-induced TNF-α release occurred under increasing concentrations of OTA, likely due to the 
cytotoxicity of OTA. The authors treated the cells with 1 µg/mL LPS which is a 10-fold higher than 
the concentration used here, and also applied OTA together with LPS. Such differences in the 
experimental set-up and also in the method of detecting TNFα (which was done by a biological 
cytotoxicity test and not by ELISA) may have caused the discrepancies of OTA effects on monocytes. 
2.3. TNF-α Release from Isolated Hepatocytes and HepG2 Cell Line 
Hepatocytes represent the major cell mass of the liver. To examine the possibility of hepatocyte 
participation in OTA-mediated TNF-α release from blood-free perfused rat liver [7,8], primary rat 
hepatocytes were prepared and kept in single-cell culture. The basal levels of TNF-α release from the 
hepatocyte cultures were higher in early cultures than those released from sinusoidal endothelial cells 
or Kupffer cells, but this level decreased with time from 295 ± 5 pg/mL at the starting point to   
47 ± 5 pg/mL at 24 h in culture treated with vehicle (Figure 3(a)). An identical decrease of TNF-α 
occurred in the presence of 2.5 µmol/L OTA in hepatocyte cultures. This means that the blood-free 
perfused rat liver hepatocytes do not contribute to OTA-mediated TNF-α release. On the other hand, 
cytokine release was observed in the presence of 0.1 µg/mL LPS. Under LPS, the typical dropping of 
late TNF-α levels failed to occur and, instead, some slight increase was observed. This increase was 
significant at P < 0.05 at 1.5 and 2 h, became significant at P < 0.01 at 4 h, and then was highly 
significant at P < 0.001 after 24 h, at which time point it was three times above the initial TNF-α 
concentrations. Furthermore, in this study HepG2 cells (Figure 3(b)), an established in vitro model for 
human liver parenchymal cells, were used. TNF-α basal levels in the culture medium treated with 
vehicle increased only from 30 pg/mL to 36 pg/mL after 24 h. Neither 2.5 µmol/L OTA nor 0.1 µg/mL 
LPS altered the TNF-α concentrations in HepG2 cells when compared with untreated controls at any 
time point indicated. Thus, isolated hepatocytes and HepG2 cells failed to show any TNF-α release 
under OTA. 
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Figure 3. TNF-α concentrations were measured in incubation media of isolated cells in cell 
culture at 0, 0.5, 1, 1.5, 2, 4 and 24 h indicated by single columns 1–7, respectively. The 
cells were exposed to vehicle ( ), 2.5 µmol/L OTA ( ) or 0.1 µg/mL LPS ( ). 
Panel (a) Hepatocytes. Panel (b) HepG2 cell line. OTA and LPS were added 1hr after zero 
samples, (see Materials and Methods section). Values represent the mean ± SEM of three 
cell preparations for each group (* P < 0.05; ** P < 0.01; *** P < 0.001) (TNF-α Release 
from Isolated Hepatocytes and HepG2 Cell Line). 
 
 
2.4. TNF-α Release from Isolated Sinusoidal Endothelial Cells and L929 Cell Line 
Sinusoidal endothelial cells, together with Kupffer cells, line the liver sinusoids. The basal TNF-α 
release from separately prepared and cultured endothelial cells treated with vehicle (Figure 4(a)) was 
45 pg/mL at time point zero and 220 ± 10 pg/mL after 24 h. In the presence of 2.5 µmol/L OTA, the 
TNF-α concentrations increased to identical levels, i.e., from 49 pg/mL at time point zero to   
230 ± 10 pg/mL after 24 h, indicating a lack of effect of OTA. In contrast, after adding 0.1 µg of 
LPS/mL into the incubation medium, a significant TNF-α release occurred as early as 4 h (P < 0.001) 
and reached 2000 ± 70 pg/mL after 24 h.  Toxins 2010, 2 
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Figure 4. TNF-α concentrations were measured in incubation media of isolated cells in cell 
culture at 0, 0.5, 1, 1.5, 2, 4 and 24 h indicated by single columns 1–7, respectively. The 
cells were exposed to vehicle ( ), 2.5 µmol/L OTA ( ) or 0.1 µg/mL LPS ( ). 
Panel (a) Sinusoidal endothelial cells. Panel (b) L929 cell line. OTA and LPS were added 
1 h after zero samples were taken (see Materials and Methods). Values represent the mean 
± SEM of three cell preparations for each group, (* P < 0.05; ** P < 0.01; *** P < 0.001) 
(TNF-α Release from Isolated Sinusoidal Endothelial Cells and L929 Cell Line). 
 
We could not detect any significant release of TNF-α from rat liver sinusoidal endothelial cells 
exposed to OTA. TNF-α was, however, released from a human liver sinusoidal endothelial cell line 
during re-oxygenation injury following hypoxia. Here, the cytokine was released significantly in a 
time-dependent manner, while sinusoidal endothelial cell function decreased [28]. In addition, rat 
sinusoidal endothelial cells expressed TNF-α mRNA after i.v. injection of plasmid DNA attached to a 
cationic liposome complex (lipoplex) [29]. 
The connective-tissue mouse L929 cell line is a sensitive cell line for the apoptotic effects of  
TNF-α [30,31], indicating the presence of TNF-α receptors on the cells. These cells have been used as 
a biological marker to measure TNF-α-mediated cytotoxic effects by TNF-α inducers. In our Toxins 2010, 2 
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experiments, the cells showed no TNF-α release upon exposure to vehicle or OTA (Figure 4(b)). In 
contrast, 0.1 µg/mL of LPS caused a slight release of TNF-α at 24 h, albeit much lower than in any 
other cell line. TNF-α concentrations were 91 ± 5 pg/mL under LPS after 24 h, which was significant 
at P < 0.001 in comparison to cells treated with vehicle (36 pg/mL). 
From this data, we conclude that the release of TNF-α from non-macrophage cells such as 
hepatocytes, sinusoidal endothelial cells and L929 cells is in principle feasible but these cells did not 
respond to OTA under our cell culture conditions. However, cells released TNF-α upon incubation 
with LPS. A likely explanation for this discrepancy is to assume separate signaling mechanisms of 
OTA versus LPS on the different cell types. 
2.5. Mechanism of OTA/LPS Mediated TNF-α Release: The Role of NF-κB  
In all positive cells responding to both stimuli, the effects occurred more rapidly under LPS than 
under OTA. This also indicates that different signal cascades are involved for each of these two 
stimuli. Although far from being understood, earlier experiments have indicated that OTA-induced 
TNF-α release from the liver is likely to occur via the NFκB transcription factor pathway [7,9]. For 
understanding the mechanistic signals beyond OTA and LPS-mediated TNF-α release, we studied the 
ability of both stimuli to phosphorylate NF-κB p65 and the translocation from the cytoplasm to the 
nucleus. Therefore, we selected J774A.1 cells, which responded to both stimuli by releasing TNF-α, 
HepG2 cells, which did not respond to either of them, and L929 cells, which responded to LPS but not 
to OTA. We found that both stimuli phosphorylate and activate NF-κB p65 in J774A.1 cells and 
caused translocation from the cytoplasm to the nuclear compartment (Figure 5(a)). The densitometric 
analysis of Western blots showed that the levels of pNF-κB p65 in the cell lysate were increased 
significantly in response to OTA and LPS (121% ± 9 and 148% ± 15, respectively). The cytosolic 
levels of pNF-κB p65 were reduced significantly in response to both stimuli (83% ± 8 and 50% ± 10, 
respectively), this reduction resulted from translocation from the cytoplasm to the nucleus, due to the 
nuclear level of pNF-κB p65 increasing (142% ± 11 and 159% ± 15, respectively) in comparison with 
cells treated with the vehicle (Figure 5(b)). In contrast, both failed to activate NF-κB p65 in HepG2 
cells. In these cells, the nuclear compartment was devoid of phosphorylated NF-κB p65. However, our 
data showed that LPS reduced the cytosolic level of pNF-κB p65 to 68% ± 10 of basal level (Figure 5c 
and 5d). Interestingly, both stimuli could phosphorylate NF-κB in L929 cells, the levels detected in 
cell lysate were 151% ± 17 in response to OTA and 197% ± 13 in response to LPS in comparison with 
cells treated with the vehicle only. In these cells, LPS caused slight translocation to the nucleus, the 
cytosolic level was 190% ± 20, while the nuclear level was 117% ± 10 in comparison with vehicle 
(Figure 5e and 5f). Obviously, TNF-α release in cells responsive to OTA or LPS was triggered via  
NF-κB, which was not activated in non-responsive cells. Our data also confirms findings of Ferrante et 
al., 2008, showing that a low concentration of OTA (3 µM) induced NF-κB activation in J774A.1 cells 
starting from even 5 min after cell exposure [32].  
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Figure 5. Panels (a), (c), and (e) Representative Western blots with antibodies detecting 
phospho-NF-κB p65 in the cell lysate, cytosolic and nuclear fractions after incubation with 
vehicle, 2.5 µmol/L OTA, or 0.1 µg/mL LPS up to 24 h. Panels (b), (d),  and (e) 
Densitometric analysis of samples obtained from cells treated with vehicle ( ),  
2.5 µmol/L OTA ( ) or 0.1 µg/mL LPS ( ). Panel (a) and (b) obtained from 
J774A.1 cells, Panel (c) and (d) from HepG2 cells, Panels (e) and (f) from L929 cells. 
Data obtained from three independent experiments, which presented as percent of control 
(mean ± SEM) after calibration for actin density. Marked columns were statistically 
different from controls (* P < 0.05; ** P < 0.01; *** P < 0.001) (The Role of NF-κB in 
OTA/ LPS mediated TNF-α release). 
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The signaling of cells upon LPS stimulation is quite well understood. To date, pure LPS is known 
to induce TNF-α by Toll like receptor TLR4 [34]. TLRs make up a family of evolutionarily conserved 
recognition molecules, which are important signal transducers for the induction of mammalian innate 
immunity responses, including cytokine responses [33]. TLR4 requires co-receptors, such as CD14 
and MD2. Altogether form a complex that activates TLR4 upon the binding at different adaptor 
proteins, including the myeloid differentiation factor 88 (MYD88) [35,36], Mac-1 [37], CXCR4, 
growth differentiation factor 5, and the heat shock proteins (HSP) 70 and 90 [38]. Then, downstream 
activation of protein kinases (e.g., IkB kinase and MAPKs) and transcription factors (e.g., NF-κB and 
AP-1) are induced, which ultimately lead to the expression of proinflammatory cytokine genes [39,40].  
OTA, on the other hand, activates mitogen-activated protein kinases (i.e., extracellular signal-regulated 
kinase 1 and 2 (ERK1/2)), c-jun amino-terminal kinase (JNK), and extracellular-regulated protein 
kinase 38 (p38) in proximal tubular cells [41,42]. In our paper, we have examined the role of 
pRaf/MEK1/2 and p38 in OTA-mediated TNF-α release in comparison with LPS. In J774A.1 cells 
OTA and LPS reduced the level of the inactive form of Raf (pRaf Ser259) which increases the 
phosphorylation of MEK 1/2 at Ser217/221. However, only OTA was able to phosphorylate p38 at 
Thr180/Tyr182 (Figure 6(a)). Obviously, both pathways were used to activate NF-κB in mouse 
monocyte macrophage cell line in response to OTA (Figure 6(a)). The densitometric analysis of 
phosphorylated levels of NF-κB by OTA revealed lower levels than that induced by LPS. This 
corresponds to the lower TNF-α release compared with LPS.  
In contrast, in L929 cells OTA and LPS increased the level of pRaf Ser259, which suppresses MEK 
1/2 Ser217/221 (Figure 6(b)) and, which occurred in parallel with p38 dephosphorylation   
(Figure 6(b)). It seems that the activation of NF-κB and TNF-α release from L929 cells response to 
LPS occurred without pRaf/MEK 1/2 or p38 activation. This provides evidence that LPS mediated 
TNF-α release occurs via several pathways at the same time.  
In monocyte macrophage cells, LPS uses membrane-bound CD14 [43,44]; whereas, soluble CD14 
is retrieved in endothelial cells, as these cells lack the membrane bound CD14 form [44–46]. Thus, 
differential and cell-specific signaling has already been shown for LPS and could also explain why 
OTA only partially mimicked LPS.  
An alternative explanation for the lack of p38 occurrence in J774A.1 cells under LPS stimulation 
might be that the time point of our measurements at 24 h was too late for the activation kinetics of p38. 
However, because in all monocyte macrophage cells under study the toxins OTA and LPS continued to 
stimulate TNF-α release over the whole incubation time of 24 h we regard even the p38 signals at late 
time points confirmative. However, the effects on earlier time points including kinetic studies on 
signaling pathways will deepen the conclusions 
Taken together, our data suggest differential and cell-specific signaling for TNF-α release, 
explaining why OTA only partially mimicked LPS. In this respect, OTA should trigger TNF-α release 
via the classical macrophagocytic signaling cascade, which involves TLR4, CD14, pRaf/MEK 1/2 or 
p38 and NF-κB. This would help to understand the observed activation of the pro-inflammatory 
response on distinct effector cells. Also, due to its different cell specificity, OTA may be a useful tool 
for studying selectively this type of TNF-α release mechanism. 
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Figure 6.  Panels (a) and (c) Representative Western blots with antibodies detecting 
phospho-Raf Ser259, phospho-MEK1/2 (Ser217/221), phospho-p38 (Thr180/Tyr182), and 
actin. Cells were incubated with vehicle, 2.5 µmol/L OTA, or 0.1 µg/mL LPS up to 24 h. 
Panels (b) and (d) Densitometric analysis of samples obtained from cells treated with 
vehicle ( ), 2.5 µmol/L OTA ( ) or 0.1 µg/mL LPS ( ). Panel (a) and (b) 
obtained from J774A.1 cells, while Panel (c) and (d) from L929 cells. Data obtained from 
three independent experiments, are presented as percent of control (mean ± SEM) after 
calibration for actin density. Marked columns were statistically different from controls (* P 
< 0.05; ** P < 0.01; *** P < 0.001) (OTA/ LPS mediated TNF-α release triggered via 
pRaf/MEK 1/2 and p38 pathways in J774A.1 cells). 
 
 
3. Materials and Methods 
3.1. Chemicals and Reagents 
Ochratoxin A was purchased from CSIR Food Science and Technology, Pretoria, South Africa; it 
was free of lipopolysaccharide contamination as tested using the Limulus Amebocyte Lysate 
Endosafe
® KTA test kit from Charles River Wiga Sulzfeld, Germany. Lipopolysaccharide (E. coli 
serotype 0111:B4, product no. L-3012), collagen type VII from a rat tail, heat fetal calf serum, trypan 
blue, modified HANK's Ca
2+ free balanced salt solution and modified HANK's balanced salt solution 
pRaf Ser259 
pMEK1/2 Ser217/221 
Actin 
J774A.1 cells
pP38 Thr180/Tyr182 
OTA (2.5µM) − + − 
LPS (0.1µg/ml) − − + 
(a) 
L929 cells 
Actin 
pP38 Thr180/Tyr182 
pMEK1/2 Ser217/221
pRaf Ser259 
OTA (2.5µM) − + − 
LPS (0.1µg/ml) − − + 
(c) Toxins 2010, 2 
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with Ca
2+ were purchased from Sigma-Aldrich Co. Steinheim, Germany. Collagenase type CIS 212 
U/mg and RPMI 1640 medium were purchased from Biochrom AG, Berlin, Germany. HEPES was 
purchased from SERVA Electrophoresis GmbH, Heidelberg, Germany. Penicillin, streptomycin, 
trypsin/ EDTA, and Dulbeccos modified Eagles medium (DMEM) were purchased from GIBCO
TM, 
Paisley, Scotland. DMSO and collagenase type NB 4 from Cl. histolyticum 0.161 PZU/mg was from 
SERVA Electrophoresis GmbH, Heidelberg, Germany. DNAase I was obtained from Boehringer-
Mannheim GmbH, Mannheim, Germany, and Nycodenz
® 5-(N-2,3-dihydroxypropylactemido)-2,4,6-
tri-iodo-N,N'-bis (2,3-dihydroxypropyl) isophthalamide was from AXIS-SHIELD PoCAS, Oslo, 
Norway. Pronase E was from E. Merck, Darmstadt, Germany. The enzyme-linked immunosorbant 
assay (ELISA) kit, Cytoscreen
®, was purchased from BioSource International, Camarillo, Canada, 
with antibodies selective for detection of rat TNF-α., LIVE/DEAD® Reduced Biohazard 
Viability/Cytotoxicity Kit No.1. (L-7013) was purchased from Invitrogen Molecular Probes, 
Karlsruhe, Germany. Cell line L929 cells (NCTC clone 929, clone strain L, connective tissue, mouse), 
J774A.1 cells (mouse monocyte macrophage cell line), and HepG2 (human hepatoma cell line) were 
generously donated by Dr. Ayub Darji, Institute of Medical Microbiology, University of Giessen, 
Germany.  
3.2. Animals  
Primary cells from the liver (Kupffer cells, sinusoidal endothelial cells, and hepatocytes) and 
peritoneal macrophages were isolated from male Wistar rats (200–280 g). The animals were fed   
ad libitum with Altromin
® standard diet and received water ad libitum. They were kept under 12 h 
light-dark cycles at 22 °C with ventilation. The health of the rats was routinely tested by sentinel 
animals, and the animals were found to be free of chronic infections and parasites. 
3.3. Isolation of Sinusoidal Endothelial and Kupffer Cells 
Kupffer cells and sinusoidal endothelial cells were isolated according
 to the collagenase/pronase 
digestion method previously described [47]. Briefly, blood-free isolated rat livers were perfused via 
the portal vein with a modified HANK's Ca
2+ free balanced salt solution at 7.5 mL/min for 5–10 min. 
Then livers were re-perfused with 80 mL RPMI 1.640 medium containing 34.4 mg/mL pronase E for 
10
 min at a flow rate of 10 mL/min. The medium was replaced by 100 mL RPMI 1640 medium 
containing 40 mg collagenase type CIS and 22.6 mg pronase E, and the livers were re-circulated for  
30 min at 20 mL/ min with gassing by air containing 5% CO2. After that, the livers were dissected, and 
the tissues were digested for 15–30 min in 120 mL RPMI 1.640 medium containing 20 mg collagenase 
type CIS, 5.3 mg/mL pronase E, and 5 mg/mL DNase. During the
 incubation, the pH was carefully 
controlled to 7.4–7.6
 by gassing with air containing 5% CO2 and by adding small amounts
 of 0.1 M 
NaOH. Subsequently, the cell suspension was filtered
 through sterile mesh 300 µm into three tubes and 
centrifuged (1.800 rpm, 10 min at 4 °C).
 The pellets were re-suspended in 10 mL HANK's balanced 
salt solution with Ca
2+, and then centrifuged (1,800 rpm, 10 min at 4 °C). The cell pellets were   
re-suspended in up to 6 mL maximum of HANK's balanced salt solution with Ca
2+; 14 mL of 
Nycodenz
® was also added to this suspension, which was then divided into two test-tubes. One mL of 
fresh HANK's balanced salt solution with Ca
2+ was dropped carefully on the tube’s wall to form a Toxins 2010, 2 
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clear layer above the suspension surface. The tubes were subjected to a density centrifugation at   
3,500 rpm for 20 min. Afterwards, the upper three of four formed layers from each test-tube were 
collected, and the volume was replenished to 10 mL with cold RPMI 1640 medium, mixed, and 
injected into the JE-6B elutriation system and rotor (Beckman Instruments, Inc., Palo Alto, CA, USA). 
The speed was gradually raised from 19 to 27 mL/min. The outlets were collected in tubes, which 
contained pure endothelial sinusoidal cells. The outlets starting from 32 to 51 mL/min contained pure 
Kupffer cells. The cells were collected separately and centrifuged at 1800 rpm for 10 min at 4 °C. 
Finally, the pellets were re-suspended in the RPMI 1640 medium containing 10%
 heat-inactivated fetal 
calf serum and penicillin
 (100 IU/mL) and streptomycin (100 µg/mL). The cells were counted with a 
Bürker-Türk counter, adjusted to 2 × 10
6 cells/mL, and seeded into tissue culture plates. Experiments 
were carried out under cell culture conditions. 
3.4. Isolation of Hepatocytes 
Hepatocytes were isolated by a collagenase perfusion method as previously described [48]. Briefly, 
isolated, blood-free, rat livers were placed in an experimental perfusion setup installed in a 
temperature-controlled hood. The livers were perfused with 75 mL of Ca
2+ free Krebs-Henseleit 
solution containing 60 mg collagenase type NB 4 for 15 min in a temperature-controlled hood at 37 °C 
under 95% O2/5% CO2 gassing. After that, the livers were carefully dissected, and the tissue was 
digested for 5 min in the perfusate solutions by bubbling gas. The cell suspensions were filtered
 
through double-layer sterile gauze into four test-tubes. The volume was adjusted by Ca
2+-containing 
Krebs-Henseleit solution and centrifuged at 300–400 rpm (~50 grav) for 10 min.
 The pellets were  
re-suspended in Tyrode buffer containing 5.5 mM glucose, then washed three times, and filtered
 
through four to six layers of gauze. The cells in suspension regenerated during 30 min in a shaker 
water bath adjusted to 37 °C and were gassed with 95% O2/5% CO2 gas. Finally, the cells were 
suspended in Dulbeccos Modified Eagles Medium (DMEM) containing 10%
 heat-inactivated fetal calf 
serum, penicillin
  (100 IU/mL), and streptomycin (100 µg/mL). The cells were counted under a 
microscope with a Bürker-Türk counter, adjusted to 2 × 10
6 cells/mL, and then seeded in collagen  
pre-coated tissue culture plates. Experiments were carried out under cell culture conditions. 
3.5. Peritoneal Rat Macrophage Preparation 
Peritoneal macrophages were prepared as described previously [49] with some modifications. Rats 
received 5 µg concanavalin A in 1 mL buffer i.p. five days before being killed by carbon dioxide gas. 
The abdominal skin was removed, and 50–60 mL sterile phosphate buffer containing 50 IU heparin 
and 5% glucose was injected into the abdominal cavity. Five minutes later, about 50 mL of fluid was 
aspirated and transferred to sterile test-tubes. The test-tubes were centrifuged at 1200 rpm for about 
10–15 min. Next, the supernatant was aspirated, and the cells were washed with phosphate buffer three 
times and then resuspended in DMEM supplemented with 10% fetal calf serum, 100 IU/mL penicillin, 
and 100 µg/mL streptomycin. The cell suspensions were seeded into culture plates and incubated at 
37°C with a humidified 5% CO2 atmosphere for 2 h to allow the macrophages to adhere on the flask 
bottom. The culture medium with floating cells was discarded. Adhered cells were collected with 
trypsin and re-suspended in the culture medium. Then 5 mL of 2 × 10
6 cells/mL were again seeded Toxins 2010, 2 
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into culture plates and incubated at 37 °C with a humidified 5% CO2 atmosphere for 2 h to allow the 
purified macrophages to adhere on the flask bottom again. Experiments were carried out under cell 
culture conditions. 
3.6. Cell Lines L929, HepG2, and J774A.1 
Connective-tissue-derived mouse cell line (L929), human hepatoma cell line (HepG2), and mouse 
monocyte macrophage cell line (J774A.1) were cultured under routine conditions. Briefly, the cells 
were taken out from liquid nitrogen and thawed at 37 °C in a water bath. Next they were suspended in 
DMEM supplemented with 10% fetal calf serum, 100 IU/ ml penicillin, and 100 µg/mL streptomycin. 
The cells were seeded in tissue culture plates and incubated at 37 °C in a humidified 5% CO2 
atmosphere. The cells were monitored during growth with replacement of the culture medium every 
72  h until the plates became overcrowded with cells. Then, the cells were collected with trypsin, 
resuspended in culture medium, and transferred to several culture flasks. When these plates contained 
about 10 × 10
6 cells/plate, then 5 mL of new medium was added. Experiments were carried out under 
the cell culture conditions. 
3.7. Cell Culture Conditions 
Single cell preparations, each at 2 × 10
6 cells/mL, were cultured at 37 °C in a humidified
 
atmosphere of 5% CO2 in the air and incubated in 5 mL media supplemented with 10%   
heat-inactivated fetal
 calf serum and containing penicillin/streptomycin (100 IU and 100 µg/mL). 
Freshly prepared hepatocytes and sinusoidal endothelial cells were transferred to tissue culture plates 
pre-coated with collagen, while Kupffer cells, peritoneal macrophages, and cell lines L929, J774A.1, 
and HepG2 were seeded into uncoated tissue culture plates. Primary cells and cell lines were incubated 
without OTA or LPS during a pre-experimental period of 2 h. After that, at time point zero, medium 
samples were taken. One μg/mL (2.5μmol/L) OTA or 0.1 µg/mL of LPS were added to culture media 
1 h after the zero-time sample. Whereas, the control cells or untreated were exposed to OTA vehicle. 
3.8. Sampling Schedule 
Culture medium samples were collected at 0, 0.5, 1, 1.5, 2, 4 and 24 h (end point). Samples were 
stored at −20 °C until they were analyzed by a rat TNF-α ELISA test system according to the 
company’s instruction. 
3.9. Cytotoxicity Assay 
Cytotoxicity of OTA and LPS was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay, detecting the cellular mitochondrial capacity to convert 
MTT tetrazolium salt to formazan. 300 µL of different cell suspensions (1 × 10
6 cells/mL) was seeded 
in 24 well tissue culture plates coated with collagen type I. The cells pre-incubated 2 h prior to the 
addition of OTA at concentrations 0, 2.5 and 12.5 µmol/L or 0.1 µg/mL LPS into incubation media up 
to 24, 48, and 72 h. After that, the cells were incubated with the medium containing MTT for 4 hours. 
The cells were then lysed in DMSO. Finally, the absorbance was measured at 570 nm.  Toxins 2010, 2 
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3.10. Cell Viability 
The applied concentrations of the toxins came from dose-finding experiments where concentrations 
of OTA between 0.5 and 75 µmol/L were selected; the concentrations used here were found not to 
significantly alter the viability of cells but effectively provoke TNF-alpha release. The viability of 
HepG2, L929 and J774A.1 cells were measured using LIVE/DEAD kit according to the company 
instructions. SYTO
® 10, a green fluorescent nucleic acid stain, is a highly membrane-permeant dye 
that labels all cells, including those with intact plasma membranes. DEAD Red (ethidium homodimer-2) 
is a cell-impermeant red fluorescent nucleic acid stain that labels only cells with compromised 
membranes. In brief, 300 µL of the cell suspensions (1 × 10
6 cells/mL) were seeded on sterile glass 
cover slips, then cells were treated with; 0, 2.5 and 12.5 µmol/L OTA or 0.1 µg/mL LPS for 24 h. 
After that, cells were washed with HBSS and then the dye mixture of the LIVE/DEAD kit was added 
for 15 minutes at room temperature in the dark. Finally, cells were washed with HBSS again and were 
visualized under a fluorescence microscope. Fluorescence imaging was performed on a Leica DM 
IRE2 fluorescence microscope supplied with FITC filter (excitation 490 nm, emission 520 nm) and 
Texas Red filter (excitation 596 nm, emission 620 nm) from Leica, Wetzlar, Germany. The captured 
images were analyzed with the Leica Fluorescence Workstation software (FW4000). Live cells 
appeared fluorescent green and dead cells fluorescent red. 
3.11. Cell Fractionation 
Subcellular fractionation was performed as following: cells were washed with cold PBS, then   
0.5 mL sucrose (0.25 M) containing a protease inhibitor cocktail was added for 5 min at 4 °C. After 
scraping, the content of plates was transferred into tubes. Cells were homogenized by a glass stick and 
their nuclei were pelleted by centrifugation (10 min, 3,500 rpm). The supernatant was used as cytosolic 
fraction, and nuclear pellets were re-suspended in IBP.7. containing protease inhibitor cocktail. The 
nuclear suspension was destructed by sonicating. The purity of fractionation was evaluated via 
detection of α-tubulin.  
3.12. Western Blotting 
The cells were washed with phosphate-buffered saline and lysed in IPB.7 containing protease 
inhibitor cocktail (Catalog # P2714, Sigma-Aldrich, Germany). The protein was quantified by using 
Coomassie Plus
TM Protein Assay Reagent (Pierce, Täby, Sweden). The samples were subjected to 
SDS-PAGE. The separated proteins were transferred to a polyvinylidene difluoride membrane   
(Bio-Rad, Hercules, CA), and the protein bands were subsequently probed with antibodies. 
Primary antibodies used in the analyses were phospho-NF-κB p65 (C22B4), phospho-MEK1/2 
(Ser217/221), phospho-Raf (Ser-259) (Cell Signaling Technology); Actin (c-11): sc-1615 and 
phospho-p38 (Thr180/Tyr182)-R: sc-17852-R (Santa Cruz Biotechnology, Santa Cruz, CA). 
Secondary antibodies used in the analyses were goat anti-rabbit IgG sc-2004, goat anti-mouse IgG sc-
2005 (Santa Cruz Biotechnology). The results were visualized by using the ECL or ECL plus detection 
kits (Amersham
TM GE Healthcare Bio-sciences AB, Uppsala, Sweden). Actin was used as a loading 
control. The results were analyzed with Image J version 1.34s software.  Toxins 2010, 2 
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3.13. Statistical Analysis 
The data are presented as mean ± SEM for at least three separate trials for each experiment, 
obtained from different animals. A two-way ANOVA statistical test was used for analysis of variance, 
followed by a Bonferroni t test. P values of <0.05 (*), <0.01 (**), and <0.001 (***) compared with 
control values were considered statistically significant. Data was analyzed with Graphpad Prism 5.0 
software (San Diego, CA, USA). 
4. Conclusion  
Our data indicate significantly different cell sensitivities to OTA versus LPS with respect to TNF-α 
release for the different cells and cell lines. Macrophages and macrophage-derived cell lines were most 
sensitive to both stimuli. Sinusoidal endothelial cells were less sensitive, and HepG2 cells and 
hepatocytes the the least sensitive. Inter-individual cell differences between OTA and LPS could be 
explained by different signaling pathways required for the stimuli of TNF-α release. 
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